GZMB and neoplasm: Granzyme B was shown to have 1.3-fold upregulation in CD8+ T cells from SN and 2.4-fold increased expression in CD8+ T cells from tumor compared to PBMC (p = 0.125 and p = 0.526, respectively) (Fig 2D).